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Abstract
Background: Plasmodium vivax merozoites specifically invade reticulocytes. Until recently, two reticulocyte-binding proteins
(Pvrbp1 and Pvrbp2) expressed at the apical pole of the P. vivax merozoite were considered to be involved in reticulocyte
recognition. The genome sequence recently obtained for the Salvador I (Sal-I) strain of P. vivax revealed additional genes in
this family, and in particular Pvrbp2a, Pvrbp2b (Pvrbp2 has been renamed as Pvrbp2c) and two pseudogenes Pvrbp2d and
Pvrbp3. It had been previously found that Pvrbp2c is substantially more polymorphic than Pvrbp1. The primary goal of this
study was to ascertain the level of polymorphism of these new genes.
Methodology/Principal Findings: The sequence of the Pvrbp2a, Pvrbp2b, Pvrbp2d and Pvrbp3 genes were obtained by
amplification/cloning using DNA purified from four isolates collected from patients that acquired the infection in the four
cardinal regions of Thailand (west, north, south and east). An additional seven isolates from western Thailand were analyzed
for gene copy number variation. There were significant polymorphisms exhibited by these genes (compared to the
reference Sal-I strain) with the ratio of mutations leading to a non-synonymous or synonymous amino acid change close to
3:1 for Pvrbp2a and Pvrbp2b. Although the degree of polymorphism exhibited by these two genes was higher than that of
Pvrbp1, it did not reach the exceptional diversity noted for Pvrbp2c. It was interesting to note that variations in the copy
number of Pvrbp2a and Pvrbp2b occurred in some isolates.
Conclusions/Significance: The evolution of different members of the Pvrbp2 family and their relatively high degree of
polymorphism suggests that the proteins encoded by these genes are important for parasite survival and are under
immune selection. Our data also shows that there are highly conserved regions in rbp2a and rbp2b, which might provide
suitable targets for future vaccine development against the blood stage of P. vivax.
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Introduction
Plasmodium spp. merozoites invade the host red cell via a
multistep invasion process [1]. Parasite species differ in the
preference they exhibit with respect to the type of red blood cells
they can invade, for example P. malariae is almost exclusively
observed in normocytes, while P. vivax is confined to reticulocytes.
Thus, one of the initial steps prior to invasion is the specific
recognition of the red blood cell type. For P. vivax two proteins
expressed at the apical pole of the merozoite have been identified
and implicated in reticulocyte recognition/selection, and were
named reticulocyte binding proteins (RBP) [2]. Genes related to
those coding for the RBPs of P. vivax (Pvrbp) were found in
Plasmodium species that infect humans [3,4,5,6], simians [7,8,9]
and rodents [10,11,12]. Given their crucial implication in the
invasion process, PVRBP proteins are considered to be good
vaccine candidates [1,13,14]. However, investigations aiming to
define the functional domains of Pvrbp genes or their receptors on
the reticulocyte were hampered by the fact that a practical
invasion assay for P. vivax invasion have been developed only
recently [15], and that the two genes are quite large in size (ca.
8 kb–9 kb). Thus, overlapping peptides were used to define the
binding domains of Pvrbp1 [16,17,18]. The other investigation was
confined to an assessment of Pvrbp1 and Pvrbp2 diversity in four
isolates from different geographical regions [19], which revealed a
remarkably high diversity in Pvrbp2 as compared to Pvrbp1 and its
homolog in P. falciparum and provided an indication as to the sub-
domains it might be worth to focus on in future studies.
When the complete genome of the Salvador I strain of P. vivax
was obtained [20], it was noted that there were other Pvrbp genes
present, which led to the reclassification of the Pvrbp family
(Table 1). There were two partial genes, and 7 full-length genes of
which two were pseudogenes (Pvrbp2d and Pvrbp3). The primary
aim of this study was to ascertain whether the high sequence
PLoS ONE | www.plosone.org 1 March 2012 | Volume 7 | Issue 3 | e32105diversity observed for Pvrbp2c (the new name for the gene
previously known as Pvrbp2) also characterises the newly
uncovered members of the Pvrbp family.
Materials and Methods
Ethics
This study was approved from Human Research Ethical
Committee at Ministry of Public Health, Thailand (Reference
no. 101/2550). This study utilized P. vivax infected blood samples
collected prior to treatment and after informed and written
consent from patients presenting in 2008–2009 at clinics from
Tak, Mae Hong Sorn, Prachup Kririkhan or Chantaburi
provinces, which are located in west, north, south and east
Thailand, respectively.
Blood samples
Approximatley30 ml of blood were spotted onto filter paper
(Protein saver, WhatmanH) and kept in a dry and cool place until
DNA extraction. Giemsa stained blood films were used to
determine the species present and the parasitaemia. DNA from
dried blood spots was extracted using QIAamp DNA Blood Mini
Kit (QIAGEN, Germany) following the manufacturer’s instruc-
tions, and the resulting DNA templates were stored at 220uC.
Four samples, one from each region were selected for use in this
study, after they were confirmed by PCR [21] to contain only P.
vivax, and where parasitaemias were close to 400 parasites per
microlitre of blood (about 1 parasites per 1000 RBC). Seven
additional samples (numbered TK1 to TK7) were randomly
selected from the west of Thailand (Tak province) for determina-
tion of the pvrbp2a and pvrbp2b copy number.
Reticulocyte Binding Protein (RBP) primer design and
amplification
Reticulocyte Binding Protein (rbp genes) primers were designed
based on the sequences obtained from the P. vivax Sal-I genome:
Gene ID PVX_121920, PVX_094255, PVX_101585, and
PVX_101495, which code for Pvrbp2a, Pvrbp2b, Pvrbp2d (pseudo-
gene) and Pvrbp3 (pseudogene), respectively [22]. Given their large
size (around eight kb), six overlapping 1.5 kb PCR fragments were
amplified for each gene (eight fragments for the 8.7 kb Pvrbp3
gene). All primers and annealing temperature are shown in (Table
S1). Two microlitres of the DNA template were used to initiate
PCR amplification that was carried out in a total volume of 20 ml
in the presence of 30 mM Tris-HCl, pH 8.3, 100 mM KCl,
2 mM MgCl2, 0.25 mM primers, 250 mM dNTPs and 0.02 U/ml
of Ampli Taq Gold DNA Polymerase (Applied Biosystems). The
cycling conditions were an initial denaturation 94uC for 5 minutes;
followed by 35 cycles: annealing at a defined temperature (see
Table S1) for 2 minutes, extension at 72uC for 2 minutes,
denaturation 94uC for 1 minute; and a final extension at 72uC
for 20 minutes. PCR products were analysed on an agarose gel
stained with Gel red (Biotium, Inc., CA, USA) and visualized
under UV light. All amplicons were immediately stored in 220uC
until cloning process.
RBP cloning and sequence analysis
The PCR products from each gene were cloned into pCR4
Topo vector (TopoH TA cloning Kit, Invitrogen), and the resulting
plasmids were sequenced using BigDye v3.1 Terminator (Applied
Biosystems) and analyzed on an ABI 730XL (Applied Biosystems).
Sequences were generated from both forward and reverse strands.
Only single nucleotide polymorphisms (SNPs) that were observed
in two or more fragments obtained from independent PCR
amplifications were considered to be confirmed and unlikely to
result as an artefact of the fidelity of the polymerase.
Copy number determination
The copy number of Pvrbp2a and of Pvrbp2b gene was estimated
by a quantitative real-time SYBR Green PCR assay, as previously
described [23]. Primers for these two genes were designed
according to their conserved regions (Table S2). The qPCR
method utilized a plasmid [vector pCR2.1H (Topo TA cloning kit,
Invitrogen)] containing the reference P. vivax aldolase gene
(GenBank Acc. No. AF247063) (single copy standard), and the
gene of interest. Real-time PCR was run in the LightCyclerH 480
(Roche Applied Science) using the following thermocycler
program: 10 minutes of pre-incubation at 95uC before conducting
45 cycles of 10 seconds at 95uC, 5 seconds at 60uC and
10 seconds at 60uC. Subsequent to this, the melting curve was
set for 0 second initiating temperature at 95uC, 15 seconds at
60uC, continuous at 72uC and cool down at 40uC 30 seconds. The
reaction volume for each sample was 20 ml, and the reactions were
placed in a 96-well plate (Applied Biosystems
TM) in the presence of
16SYBRGreen buffer (Roche Applied Science), 2.5 mM MgCl2,
250 nM of each primer, and 2 ml of DNA. At the end of each
reaction, Cycle threshold (Ct) was evaluated and melting curves
were acquired and analyzed. The DDCt calculation for the relative
quantification of P. vivax gene target was used as follows DDCt=Ct
Table 1. Chromosomal location of the Plasmodium vivax
Reticulocyte Binding Protein genes.
Name Strain Chromosome
Pvrbp1a Sal-I 7
Pvrbp1b Sal-I 7
Pvrbp2a Sal-I 14
Pvrbp2b Sal-I 8
Pvrbp2c Sal-I 5
Pvrbp2 (partial) Sal-I 5
Pvrbp2d Sal-I 14
Pvrbp2 (partial) Sal-I 14
Pvrbp3 Sal-I 14
doi:10.1371/journal.pone.0032105.t001
Table 2. Genetic diversity within the Plasmodium vivax
Reticulocyte binding protein genes.
Gene n Size SNP (n) Reference
NS S
Pvrbp1 4 8499 25 3 Rayner et al. [19]
Pvrbp2c 4 8454 489 151 Rayner et al. [19]
Pvrbp2a 4 7464 55 18 This study
Pvrbp2b 4 7959 51 13 This study
Pvrbp2d 4 8495 34 28 This study
Pvrbp3 4 8702 67 48 This study
Note: n=number of sequenced isolates; Size=size of the gene analyzed with
the non-coding regions excluded; SNP (n)=number of single nucleotide
polymorphisms; NS=non-synonymous substitutions; S=synonymous
substitutions.
doi:10.1371/journal.pone.0032105.t002
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was calculated in N-fold changes by using equation as showing: N-
fold copies in isolate=2
2DDCt [24].
Results and Discussion
The sequences of the four recently discovered members of the
Pvrbp genes (Pvrbp2a, Pvrbp2b, Pvrbp2d, and Pvrbp3) (Table 1) were
obtained from 4 P. vivax isolates collected from distinct regions of
Thailand (Accession numbers JN122379–JN122425 & JN172857–
JN172908; totalling 130.5 kb of sequences). In all four P. vivax
isolates from Thailand the Pvrbp2d, Pvrbp3 were confirmed to be
pseudogenes, as was found for those in Sal-I. The sequences
obtained for all the genes were then aligned with those of the P.
vivax Sal-I strain genes. The overall results of this analysis are
presented in Table 2, and schematically in Fig. 1 & 2. The
sequences of the genes from the Thai P. vivax isolates differed
significantly from those of the Sal-I strain with about 8 to 13 SNPs
per 1000 bp. This level of diversity is closer to that observed for
Pvrbp1 (3.3 SNP per 1000 bp) than to that for Pvrbp2c (76.4 SNPs
per 1000 bp) (Table 2). It should however, be pointed out that
more than half of the SNP’s detected were observed only once,
and it is possible that some were artefacts of the amplification
reaction. Confirmation by sequencing of all the gene fragments
from two independent PCR amplifications could not be carried
out for logistic regions: this would have represented an extra
130 kb of sequences to obtain). If only the confirmed SNP’a are
taken into consideration, then the level of diversity (3 to 4 SNPs
Figure 1. Schematic representation of the Pvrbp2a (A) and Pvrbp2b (B) genes. In each panel, the location of the fragments cloned is
indicated below the gene model. Above the gene model, synonymous mutations are indicated by vertical bars below the horizontal bar that
represents the gene, whereas non-synonymous mutations are place above this horizontal bar. SNPs that have been confirmed from two independent
PCR amplifications are shown as solid lines, whereas those observed only once are represented by dotted lines. The nature and location of confirmed
SNPs are also provided as tables, with the non-synonymous mutations highlighted in olive green.
doi:10.1371/journal.pone.0032105.g001
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The ratio of non-synonymous (NS) to synonymous (S) mutations
for Pvrbp2a and Pvrbp2b was 3.0 and 3.1, respectively, which was
comparable to that noted for Pvrbp2c (2.4 and 3.9) and lower than
that recorded (4.5) for Pvrbp1 [19] (Table 2). The NS/S ratios for
the two pseudogenes Pvrbp2d and Pvrbp3, was 1.2 and 1.4,
respectively, as would be expected for non-functional genes. The
extent of diversity observed was more restricted between the genes
of the four isolates from Thailand, as compared to that noted
when the Sal-I sequences were considered. It should also be noted
that for all the mutations observed for any particular residue, the
nucleotide substituted was invariably the same in the genes from
the four isolates (except for one synonymous SNP at position 7023
of the Pvrbp3 pseudogene). There was some degree of clustering of
the non-synonymous mutations in Pvrbp2b, suggesting that
different domains might be under differential selective pressure.
However, a similar pattern of clustering was observed for the two
pseudogenes.
It had been previously noted that some P. falciparum lines
harbour multiple copies of one of the Pvrbp homologues, Pfrh1
[25]. Variation in the copy number of Pvrbp2a and Pvrbp2b were
sought in seven isolates collected from west Thailand (Tak
province), and this was found in two of these P. vivax isolates:
there were two copies of Pvrbp2b in one, and there were two copies
of both Pvrbp2a and Pvrbp2b in the other (Fig. 3). The functional
significance, if any, of these copy number variations is not known
at present. This would also require a survey of a larger number of
P. vivax isolates, and ultimately a means to ascertain if there is a
link between the number of Pvrbp copy number and a particular
parasite phenotype. Nonetheless, one could speculate that the
pseudogenes (Pvrbp2d and Pvrbp3) might have been derived from
genes present as multiple copies. It should be confirmed that
Figure 2. Schematic representation of the Pvrbp2d (A) and Pvrbp3 (B) genes. In each panel, the location of the fragments cloned is indicated
below the gene model. Above the gene model, synonymous mutations are indicated by vertical bars below the horizontal bar that represents the
gene, whereas non-synonymous mutations are place above this horizontal bar. SNPs that have been confirmed from two independent PCR
amplifications are shown as solid lines, whereas those observed only once are represented by dotted lines. The nature and location of the confirmed
SNPs are also provided in the tables, with the non-synonymous mutations highlighted in olive green. As these two genes are pseudogenes, the
consequence of the SNP, synonymous or non-synonymous, has been predicted assuming that a continuous reading frame.
doi:10.1371/journal.pone.0032105.g002
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evidence for the protein encoded by one of the homologues of the
Pvrbp genes in P. falciparum (Pfrh3) that was considered to be a
pseudogene, was detected by proteomic analysis in sporozoites
extracts [26].
Given that the sequence data presented was derived from four
isolates only, it is felt that any conclusions that can be drawn from
the pattern of mutations are at best speculative. For example, it
would be interesting to investigate whether a higher degree of
genetic diversity would be observed for P. vivax from the west of
Thailand as a result of the relatively higher incidence of this
parasites as compared to the other areas of Thailand (Malaria
Cases Report (Report 506): Annual report for the fiscal year 2006–
2007 by provinces, Department of Communicable Disease
Control, Ministry of Public Health, Bangkok 2008). Similarly, it
is not known whether the nature and extent of the diversity
observed is specific to the local parasite populations: P. vivax
circulating in Thailand as compared to those circulating in
geographically isolated populations of P. vivax, such as; Papua New
Guinea, Afghanistan, Madagascar or South America. Until such a
time when cloning and sequencing of high numbers of large genes
becomes economically justifiable, one can envisage studies that
target particular sub-domains of the Pvrbp genes.
Conclusion and Future Studies
To our knowledge, this is the first investigation of the genetic
diversity of the recently uncovered full-length members of the
Pvrbp family [20]. There is still very little known about the specific
role of the corresponding proteins. Nonetheless, the high number
of non-synonymous mutations in rbp2a and rbp2b suggest that they
are likely to be under active selection and occurrence of P. vivax
strains in which one or both are present as multiple copies is
consistent with an important role in the survival of the parasite. A
recently validated invasion inhibition assay employing P. vivax field
isolates [15] makes it possible to envisage investigations of the
functional role of the various PvRBP proteins or domains thereof,
and ultimately to establish if any can serve as a useful target for a
future vaccine against P. vivax.
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